Trial record 1 of 2 for:
NCT02273375
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02273375 |
|
Recruitment Status :
Active, not recruiting
First Posted : October 24, 2014
Last Update Posted : April 3, 2020
|
Sponsor:
Canadian Cancer Trials Group
Collaborators:
Intergroupe Francophone de Cancerologie Thoracique (IFCT)
Australasian Lung Cancer Trials Group
National Health and Medical Research Council, Australia
National Cancer Institute (NCI), Naples
Central and Eastern European Oncology Group
Dutch Society of Physicians for Pulmonology and Tuberculosis
Korean Cancer Study Group
Fundación GECP
West Japan Oncology Group (WJOG)
Chinese Thoracic Oncology Group
Information provided by (Responsible Party):
Canadian Cancer Trials Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | January 31, 2023 |
| Estimated Study Completion Date : | January 31, 2024 |